Skip to main content
. 2017 Apr 7;8:179. doi: 10.3389/fphar.2017.00179

Table 3.

Patients' characteristics with CHRs.

Patients characteristics Treatment schedule
Protocol by Packer et al., N = 6 Protocol SIOP LGG 2004, N = 10
Boys/girls 4/2 4/6
Median age at reaction months (range) 20 (12–60) 39.5 (12–72)
Median No. of infusion (range) 7 (3–9) 8.5 (5–11)
Median cumulative dose (mg/m2) 1225 (525–1,575) 4675 (2,750–6,050)
Grade CHR 1-2 5 (83.6) 9 (90)
Grade CHR 3 1 (16.4) 1 (10)